Related Experiment Video

Updated: Mar 31, 2026

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
09:57

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization

Published on: September 20, 2024

3.9K

Narcolepsy in pediatric age - Experience of a tertiary pediatric hospital

Filipa Dias Costa1, Maria Inês Barreto1, Vanda Clemente2

  • 1Pediatric Hospital, Hospital and University Center of Coimbra, Portugal.

Sleep Science (Sao Paulo, Brazil)
|October 21, 2015
PubMed

Insights

Pediatric narcolepsy, a sleep-wake disorder, requires early diagnosis and treatment for children's development. Prompt therapeutic adjustment significantly improves symptoms, school performance, and social integration in affected children.

Area of Science:

  • Neurology
  • Pediatric Sleep Medicine
  • Sleep Disorders

Background:

  • Narcolepsy is a chronic, multifactorial sleep-wake cycle disorder impacting children's development.
  • Early suspicion and intervention are crucial for managing narcolepsy in pediatric populations.
  • Key symptoms include excessive daytime sleepiness, cataplexy, hallucinations, and sleep paralysis.

Observation:

  • A retrospective study analyzed eight children diagnosed with narcolepsy, with symptom onset between 6.8 and 10.5 years.
  • Diagnostic delays ranged from 4 months to 2 years.
  • One case reported H1N1 vaccination eight months prior to symptom onset; the Multiple Sleep Latency Test (MSLT) was positive in 6 of 8 children.

Findings:

  • All children received treatment, primarily methylphenidate, with venlafaxine added in four cases.
  • One child initially received only behavioral therapy.
  • Therapeutic adjustments led to symptomatic improvement, enhanced school performance, and better social integration in all cases.

Implications:

  • Timely diagnosis and tailored treatment strategies are vital for improving outcomes in pediatric narcolepsy.
  • Pharmacological and behavioral interventions can effectively manage narcolepsy symptoms, promoting cognitive and social development.
  • Further research into narcolepsy etiology, including potential environmental triggers like vaccinations, is warranted.

Keywords:
CasuisticChildrenNarcolepsySleepiness

More Related Videos

Measuring Neural Mechanisms Underlying Sleep-Dependent Memory Consolidation During Naps in Early Childhood08:20

Measuring Neural Mechanisms Underlying Sleep-Dependent Memory Consolidation During Naps in Early Childhood

Published on: October 2, 2019

12.7K
Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD10:02

Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD

Published on: March 12, 2020

17.0K

Related Concept Videos

Narcolepsy01:07

Narcolepsy

Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.
772
Sleep-Wake Cycles01:24

Sleep-Wake Cycles

Sleep is an essential physiological process vital to maintaining overall well-being. The reticular activating system (RAS), a network of neurons in the brainstem, regulates wakefulness and sleep. While it may seem passive, sleep consists of distinct cycles, each with its unique characteristics and functions. Two key sleep phases are non-rapid eye movement (NREM) and  rapid eye movement (REM).
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
3.3K
Nightmares and Night Terrors01:18

Nightmares and Night Terrors

Nightmares and night terrors represent two distinct types of sleep disturbances that differ in timing, characteristics, and the sleeper's recall of the event. Nightmares are vivid, disturbing dreams that usually awaken the sleeper from REM sleep, a stage of sleep where brain activity is high, and dreams are most frequent. Upon awakening, individuals often have detailed recollections of their nightmares, which can include themes of threats to survival, security, or self-esteem.
Nightmares...
812
REM Sleep Behavior Disorder01:15

REM Sleep Behavior Disorder

REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
2.5K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
374
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
332